203 related articles for article (PubMed ID: 15761604)
21. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in healthy adolescents on two-dose schedule.
Chen CC; Chang MH; Lee HC; Twu SJ; Safary A
Acta Paediatr Taiwan; 1999; 40(3):157-60. PubMed ID: 10910606
[TBL] [Abstract][Full Text] [Related]
22. Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.
Van Der Meeren O; Peterson JT; Dionne M; Beasley R; Ebeling PR; Ferguson M; Nissen MD; Rheault P; Simpson RW; De Ridder M; Crasta PD; Miller JM; Trofa AF
Hum Vaccin Immunother; 2016 Aug; 12(8):2197-2203. PubMed ID: 27123743
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
24. [Experience with vaccine prophylaxis of hepatitis B among different groups of children].
Moskovskaia IA; Kuzina LE; Anichkina TV; Aleshin IK; Ul'ianova LA; Kuzin SN
Zh Mikrobiol Epidemiol Immunobiol; 2003; (2):42-6. PubMed ID: 12886606
[TBL] [Abstract][Full Text] [Related]
25. Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China.
Zhu F; Deckx H; Roten R; Michiels B; Sarnecki M
Pediatr Infect Dis J; 2017 Jan; 36(1):94-101. PubMed ID: 27753794
[TBL] [Abstract][Full Text] [Related]
26. Comparison study of the immunogenicity and safety of 5- and 10-microgram dosages of a recombinant hepatitis B vaccine in healthy children.
Goldfarb J; Medendorp SV; Nagamori K; Buscarino C; Krause D
Pediatr Infect Dis J; 1996 Sep; 15(9):768-71. PubMed ID: 8878218
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines.
Bryan JP; Craig PG; Reyes L; Hakre S; Jaramillo R; Harlan H; MacArthy P; Legters LJ
Vaccine; 1995 Aug; 13(11):978-82. PubMed ID: 8525691
[TBL] [Abstract][Full Text] [Related]
28. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
Keating GM; Noble S
Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of two recombinant hepatitis B vaccines in older individuals.
Treadwell TL; Keeffe EB; Lake J; Read A; Friedman LS; Goldman IS; Howell CD; DeMedina M; Schiff ER; Jensen DM
Am J Med; 1993 Dec; 95(6):584-8. PubMed ID: 8259774
[TBL] [Abstract][Full Text] [Related]
30. Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.
Oliveira MD; Martins RM; Matos MA; Ferreira RC; Dias MA; Carneiro MA; Junqueira AL; Teles SA
Mem Inst Oswaldo Cruz; 2006 May; 101(3):251-6. PubMed ID: 16862317
[TBL] [Abstract][Full Text] [Related]
31. Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.
Wang H; Cai B; Rao D; Liu M; Li Y; Liang X; Cui F; Zhang G; Wang F; Pang X; Nie L; Qiu Q; Wu J; Li L; Huang F; Zhang W
Hum Vaccin Immunother; 2016 Nov; 12(11):2921-2926. PubMed ID: 27648684
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
Vesikari T; Martin JC; Liss CL; Liska V; Schödel FP; Bhuyan PK
Pediatr Infect Dis J; 2011 Jul; 30(7):e109-13. PubMed ID: 21552183
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
Coates T; Wilson R; Patrick G; André F; Watson V
Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
[TBL] [Abstract][Full Text] [Related]
34. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital.
Catania G; Di Ciommo V; Concato C
Recenti Prog Med; 1996 Jun; 87(6):271-4. PubMed ID: 8766952
[TBL] [Abstract][Full Text] [Related]
35. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
[TBL] [Abstract][Full Text] [Related]
36. Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.
Sharma R; Ahlm C; Ostergaard L; Dowell A; Tran C; Thomas S; Eymin C
Hum Vaccin Immunother; 2015; 11(7):1709-16. PubMed ID: 25996838
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
[TBL] [Abstract][Full Text] [Related]
38. Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination.
Lin CS; Xie SB; Liu J; Zhao ZX; Chong YT; Gao ZL
Clin Vaccine Immunol; 2010 Oct; 17(10):1548-51. PubMed ID: 20719983
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B vaccine administered to children and adolescents at yearly intervals.
Halsey NA; Moulton LH; O'Donovan JC; Walcher JR; Thoms ML; Margolis HS; Krause DS
Pediatrics; 1999 Jun; 103(6 Pt 1):1243-7. PubMed ID: 10353936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
